These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 17653291)
21. Comparison of brain serotonin transporter using [I-123]-ADAM between obese and non-obese young adults without an eating disorder. Wu CH; Chang CS; Yang YK; Shen LH; Yao WJ PLoS One; 2017; 12(2):e0170886. PubMed ID: 28182708 [TBL] [Abstract][Full Text] [Related]
22. Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: a SPECT study. Chou YH; Wang SJ; Lin CL; Mao WC; Lee SM; Liao MH Bipolar Disord; 2010 May; 12(3):312-8. PubMed ID: 20565438 [TBL] [Abstract][Full Text] [Related]
23. ADAM is an effective tool for in vivo study of serotonergic function: validation in rat models. Chalon S; Bronquard C; Vercouillie J; Kodas E; Garreau L; Bodard S; Emond P; Besnard JC; Guilloteau D Synapse; 2004 May; 52(2):136-42. PubMed ID: 15034919 [TBL] [Abstract][Full Text] [Related]
25. Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates. Huang WS; Ma KH; Cheng CY; Chen CY; Fu YK; Chou YH; Wey SP; Liu JC Nucl Med Commun; 2004 May; 25(5):515-9. PubMed ID: 15100512 [TBL] [Abstract][Full Text] [Related]
26. Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study. Erlandsson K; Sivananthan T; Lui D; Spezzi A; Townsend CE; Mu S; Lucas R; Warrington S; Ell PJ Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1329-36. PubMed ID: 16133377 [TBL] [Abstract][Full Text] [Related]
27. Association between serotonin transporter availability and hostility scores in healthy volunteers - a single photon emission computed tomography study with [(123)I] ADAM. Yang YK; Yao WJ; Yeh TL; Lee IH; Chen KC; Lu RB Psychiatry Res; 2007 Apr; 154(3):281-4. PubMed ID: 17349781 [TBL] [Abstract][Full Text] [Related]
28. Imaging serotonin transporters using [123I]ADAM SPECT in a parkinsonian primate model. Ma KH; Huang WS; Huang SY; Cheng CY; Chen CY; Shen LH; Liu JC; Fu YK Appl Radiat Isot; 2008 Dec; 66(12):1799-803. PubMed ID: 18703341 [TBL] [Abstract][Full Text] [Related]
29. Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain. Choi SR; Hou C; Oya S; Mu M; Kung MP; Siciliano M; Acton PD; Kung HF Synapse; 2000 Dec; 38(4):403-12. PubMed ID: 11044887 [TBL] [Abstract][Full Text] [Related]
30. Biodistribution and radiation dosimetry of [123I]ADAM in healthy human subjects: preliminary results. Kauppinen TA; Bergström KA; Heikman P; Hiltunen J; Ahonen AK Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):132-6. PubMed ID: 12483421 [TBL] [Abstract][Full Text] [Related]
31. Association between the dexamethasone suppression test and serotonin transporter availability in healthy volunteer: a SPECT with [(123)I] ADAM study. Tsai HY; Lee IH; Yeh TL; Yao WJ; Chen KC; Chen PS; Chiu NT; Lu RB; Yang YK Eur Neuropsychopharmacol; 2012 Sep; 22(9):641-6. PubMed ID: 22356823 [TBL] [Abstract][Full Text] [Related]
32. The SPECT tracer [123I]ADAM binds selectively to serotonin transporters: a double-blind, placebo-controlled study in healthy young men. van de Giessen E; Booij J Eur J Nucl Med Mol Imaging; 2010 Aug; 37(8):1507-11. PubMed ID: 20309682 [TBL] [Abstract][Full Text] [Related]
33. Probing the association between dexamethasone-induced cortisol suppression and serotonin transporter availability among drug-free patients with major depressive disorder--a small-sample SPECT study with [¹²³I]ADAM. Tsai HC; Lin SH; Lee IH; Chen PS; Chen KC; Yeh TL; Yao WJ; Chiu NT; Lu RB; Yang YK Psychoneuroendocrinology; 2013 Nov; 38(11):2805-9. PubMed ID: 23816429 [TBL] [Abstract][Full Text] [Related]
34. Serotonin transporter availability in the midbrain and perceived social support in healthy volunteers. Huang HY; Lee IH; Chen KC; Lin SH; Yeh TL; Chen PS; Chiu NT; Yao WJ; Chen CC; Liao MH; Yang YK J Psychosom Res; 2013 Dec; 75(6):577-81. PubMed ID: 24290049 [TBL] [Abstract][Full Text] [Related]
35. Suicidal ideation modulates the reduction in serotonin transporter availability in male military conscripts with major depression: A 4-[18F]-ADAM PET study. Yeh YW; Ho PS; Chen CY; Kuo SC; Liang CS; Yen CH; Huang CC; Shiue CY; Huang WS; Ma KH; Lu RB; Huang SY World J Biol Psychiatry; 2015 Oct; 16(7):502-12. PubMed ID: 26068129 [TBL] [Abstract][Full Text] [Related]
36. Short term vs. long term test-retest reproducibility of ¹²³I-ADAM for the binding of serotonin transporters in the human brain. Hsu JW; Wang SJ; Lin CL; Hsieh WC; Lirng JF; Shen YC; Liao MH; Chou YH Psychiatry Res; 2011 Dec; 194(3):224-229. PubMed ID: 22079655 [TBL] [Abstract][Full Text] [Related]
37. Imaging the serotonin transporter using (123)I-ADAM in the human brain. Chou YH; Yang BH; Chung MY; Chen SP; Su TP; Chen CC; Wang SJ Psychiatry Res; 2009 Apr; 172(1):38-43. PubMed ID: 19239985 [TBL] [Abstract][Full Text] [Related]
38. Probing the Serotonin Transporter Availability Among Male Cigarette Smokers: A SPECT Study With [123I] ADAM. Zhao RJ; Lin SH; Lee LT; Lee IH; Chen PS; Chen KC; Yang YK J Addict Med; 2016; 10(2):89-92. PubMed ID: 26742023 [TBL] [Abstract][Full Text] [Related]
39. Change over time in brain serotonin transporter binding in major depression: effects of therapy measured with [(123) I]-ADAM SPECT. Amsterdam JD; Newberg AB; Newman CF; Shults J; Wintering N; Soeller I J Neuroimaging; 2013 Oct; 23(4):469-76. PubMed ID: 23751132 [TBL] [Abstract][Full Text] [Related]
40. Imaging of serotonin transporters and its blockade by citalopram in patients with major depression using a novel SPECT ligand [123I]-ADAM. Herold N; Uebelhack K; Franke L; Amthauer H; Luedemann L; Bruhn H; Felix R; Uebelhack R; Plotkin M J Neural Transm (Vienna); 2006 May; 113(5):659-70. PubMed ID: 16465456 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]